Skip to main content
. 2012 Jan 9;3(4):665–672. doi: 10.3892/etm.2012.447

Table IV.

Association of the -A317G and C829T polymorphisms in the DHFR gene and other clinical features with the risk of relapse of childhood acute lymphoblastic leukemia.

Modela Genotype No. (%) OR 95% CI p-valueb
-A317G (rs408626)
  Co A/A 14 (20.00) 1.00
A/G 33 (47.14) 4.80 1.26–18.24 0.021c
G/G 23 (32.86) 8.55 1.84–39.70 0.006c
  Do A/A 14 (20.00) 1.00
A/G + G/G 56 (80.00) 7.62 2.01–28.81 0.003c
  Re A/A + AG 47 (67.14) 1.00
G/G 23 (32.86) 2.94 0.86–10.06 0.084
C829T (rs34764978)
  Co C/C 10 (14.29) 1.00
C/T 53 (75.71) 6.50 1.47–28.67 0.013c
T/T 7 (10.00) 14.00 1.13–172.63 0.039c
  Do C/C 10 (14.29) 1.00
C/T + T/T 60 (85.71) 7.00 1.60–30.54 0.010c
  Re C/C + C/T 63 (90.00) 1.00
T/T 7 (10.00) 3.00 0.348–26.55 0.323
Gender
  Female 25 (35.71) 1.00
  Male 45 (64.29) 1.38 0.49–3.92 0.540
Risk by age
  1–9 years (low risk) 18 (25.71) 1.00
  <1 and >9 years (high risk) 52 (74.29) 4.54 1.14–18.09 0.032c
Leukocytes at diagnosis
  <50,000/mm3 18 (25.71) 1.00
  >50,000/mm3 52 (74.29) 7.64 1.90–30.73 0.004c
a

Genetic model: Co, codominant; Do, dominant; Re, recessive.

b

Obtained by logistic regression analysis;

c

Significant p<0.05; OR, odds ratio; 95% CI, 95% confidence interval.